US98419M1009 - Common Stock
Over the last six months, Xylem’s shares have sunk to $123.38, producing a disappointing 12.3% loss - a stark contrast to the S&P 500’s 12.1% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
No one likes it when their investment posts a double miss on yearly guidance.
/PRNewswire/ -- ElectraMet® has entered into a memorandum of understanding with Xylem Inc. (NYSE: XYL) to explore collaboration on scalable peroxide and metals...
An analyst downgrade hit the stock today, but that could be creating a buying opportunity.
Xylem beat second-quarter estimates, but investors were not impressed.
Xylem beat second-quarter estimates, but investors were not impressed.
XYL stock results show that Xylem beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.